LFA
BLFS icon

LGT Financial Advisors’s BioLife Solutions BLFS Stock Holding History

LGT Financial Advisors’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-118
Closed -$3.06K – 351
2024
Q4 		$3.06K Buy
+118
New +$2.94K 0.01% 631
2023
Q4 		– Sell
-172
Closed -$2.38K – 860
2023
Q3 		$2.38K Buy
+172
New +$2.71K ﹤0.01% 797

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

LGT Financial Advisors's BLFS Position: Q1 2025 in Review

LGT Financial Advisors sold out of BioLife Solutions (BLFS) in Q1 2025, closing a stake of 118 shares — an estimated $3.06K sold.

LGT Financial Advisors first reported a position in BLFS in Q3 2023 and held it in 2 quarters. The position peaked at $3.06K in Q4 2024. 188 funds tracked by Wall St. Rank hold BLFS as of Q1 2025.

  • LGT Financial Advisors reported no remaining BioLife Solutions position as of Q1 2025 after selling out during the quarter.
  • LGT Financial Advisors sold 118 BioLife Solutions shares in Q1 2025, an estimated $3.06K.
  • LGT Financial Advisors first reported a position in BioLife Solutions in Q3 2023 and held it in 2 quarters.
  • LGT Financial Advisors's BioLife Solutions position peaked at $3.06K in Q4 2024.
  • 188 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2025.

Based on LGT Financial Advisors's 13F filing for Q1 2025, filed 8 May 2025.